Oncotarget is an open access medical journal. It is peer-reviewed on a weekly basis and covers research on all oncology aspects. The journal was established in 2010 and is published by Impact Journals. Andrei V. Gudkov and Mikhail Blagosklonny are the chief editors. Oncotarget now offers free Altmetric article reports as part of their new journal platform to provide synchronized tracking of the coverage of items in traditional and digital media channels. Oncotarget has published 370 papers on topics related to oxygen since its inception in 2010. Gregg L. Semenza and William G. Kaelin, Jr. are members of Oncotarget. They won the Lasker Award for the discovery of the pathway of sensing oxygen in 2016. Oncotarget is a traditional journal that is multidisciplinary and has free access. It publishes papers online on weekly issues. Every article or item can be printed in case there is a particular demand. See: https://www.ncbi.nlm.nih.gov/pubmed/?term=blagosklonny
The mission of Oncotarget is to:
• Widely and rapidly make scientific results available to all Oncotarget readers.
• To enable exceptional discoveries to be shared fast.
• To maximize research impact through insightful review.
• To foster clinical and basic science applications to fight disease.
• To link various fields of biomedical science.
Oncotarget assists all researchers in contributing to the progress of science. This is made possible with the leadership of the leading prominent scientists. The intention of the journal is to see people living lives without the disease. The success that Oncotarget has experienced has encouraged them to launch other sections apart from oncology. The word Oncotarget encompasses all pathways, molecules, and cellular functions that are common in aging and cancer, lymphocytes and neurons, microbes and cancer cells, atherosclerosis, and neurodegeneration.
Oncotarget has an experienced editorial board that ensures only the best quality issues are published. They also play a role in the success of the journal due to their unending devotion and experience gained over the years. Oncotarget is now featuring other issues on Immunology, Microbiology, Chromosome, Cardiology, Aging and Gerotarget, Metabolism, all areas of Pharmacology, Mol Biology and Cell, Endocrinology, Neuroscience, as well as neuropathology.
Oncotarget allows authors from outside to submit any articles they have on oncology. They give opportunities to writers who are interested in writing on the subject of Oncology. They also insist that all work submitted should pass all their ethical tests and that it should be of top quality. Quality is everything.
Learn about Oncotarget on DovePress.com
Rainbow34 December 25, 2016
Posted In: Medical Journals